Literature DB >> 1438645

Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls.

E Eriksson1, C Sundblad, P Lisjö, K Modigh, B Andersch.   

Abstract

Serum levels of progesterone, total testosterone, free testosterone, androstenedione (A2), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulphate (DHEAS), 17-OH-progesterone (17-OHP), and sex hormone binding globulin (SHBG) were measured in the follicular phase, around ovulation, and in the luteal phase of 11 women with severe premenstrual irritability and dysphoria and in 11 age-matched controls with no premenstrual complaints. Serum levels of free testosterone were significantly higher in the subjects with premenstrual syndrome (PMS) than in the controls in the luteal phase (p < 0.01), the follicular phase (p < 0.05), and around ovulation (p < 0.01). DHEA levels were significantly higher in the PMS subjects, as compared to controls, around ovulation (p < 0.05), while 17-OHP levels were higher in the PMS women in the luteal phase (p < 0.05). With respect to the other steroids measured, as well as SHBG, no differences between PMS subjects and controls were found. These results indicate a possible involvement of androgens in the pathophysiology of premenstrual irritability and dysphoria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438645     DOI: 10.1016/0306-4530(92)90058-f

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  16 in total

1.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

Review 2.  Neuroendocrine effects on mood.

Authors:  Margaret G Spinelli
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

3.  Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.

Authors:  Fan Guang-Sheng; Bian Mei-Lu; Cheng Li-Nan; Cao Xiao-Ming; Huang Zi-Rong; Han Zi-Yan; Jing Xiao-Ping; Li Jian; Wu Shu-Ying; Xiong Cheng-Liang; Xiong Zheng-Ai; Yue Tian-Fu
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 4.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

Review 5.  Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?

Authors:  Uriel Halbreich; P M Shaughn O'Brien; Elias Eriksson; Torbjörn Bäckström; Kimberly A Yonkers; Ellen W Freeman
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Emotion regulation in women with premenstrual dysphoric disorder.

Authors:  Nicole Petersen; Edythe D London; Letty Liang; Dara G Ghahremani; Rachel Gerards; Linda Goldman; Andrea J Rapkin
Journal:  Arch Womens Ment Health       Date:  2016-05-07       Impact factor: 3.633

7.  Influence of sex steroid hormones on the adolescent brain and behavior: An update.

Authors:  Pilar Vigil; Juan Pablo Del Río; BÁrbara Carrera; Florencia C ArÁnguiz; Hernán Rioseco; Manuel E Cortés
Journal:  Linacre Q       Date:  2016-08

Review 8.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

Review 9.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

10.  Association of testosterone levels and future suicide attempts in females with bipolar disorder.

Authors:  Leo Sher; Michael F Grunebaum; Gregory M Sullivan; Ainsley K Burke; Thomas B Cooper; J John Mann; Maria A Oquendo
Journal:  J Affect Disord       Date:  2014-05-05       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.